TELK

Telik Climbs In Pre-Market On Pair Of Drugs Reaching Preclinical Development Milestones - 08/22 - 08:54 AM ET

Telik's Proteasome Inhibitor Program Meets a Preclinical Development Milestone - 08/21 - 04:05 PM ET

Telik's Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone - 08/21 - 04:05 PM ET

ReceptorBio Inc enters into diabetes license agreement with Telik Inc - 08/20 - 10:40 AM ET

Telik Announces Diabetes License Agreement With ReceptorBio - 08/19 - 08:00 AM ET

ReceptorBio Announces Diabetes License Agreement With Telik - 08/19 - 08:00 AM ET

Telik Announces Financial Results For 2008 Second Quarter - 08/11 - 04:05 PM ET

TELK: Q2 Earnings Call @ 16:30 ET Today [delayed] - 08/11 - 01:51 PM ET

Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast - 08/04 - 04:05 PM ET

Telik's TRAP Drug Discovery Technology Surpasses 3 Million Molecular Fingerprint Milestone - 07/22 - 08:00 AM ET

Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters - 07/08 - 08:00 AM ET

Telik Finishes At New Low - 06/13 - 04:27 PM ET

Wall Street Media Presents a Video Highlight of Telik Inc., (NASDAQ: TELK) - 06/11 - 12:30 PM ET

TELK: To Present At Needham Bio & Medical Tech Conference @ 10:00 ET [delayed] - 06/11 - 08:22 AM ET

TELK: Notice of EU Patent Allowance for Compounds Related to TELINTRA(R) - 06/11 - 07:45 AM ET

Telik Announces Patents on Compounds Related to TELINTRA - 06/10 - 04:05 PM ET

Telik Announces Presentation and Webcast at Needham Biotechnology Conference - 06/05 - 04:05 PM ET

TELK: Begins Two Phase II Trials w/TELINTRA(R) for MDS and CIN - 05/21 - 08:28 AM ET

Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies - 05/20 - 04:05 PM ET

Telik Announces First Quarter 2008 Financial Results - 05/08 - 04:05 PM ET

Page 1 of 4     1  2   3   4      Previous  |  Next

<< Back to Stock Index